Clinical trial
Exploratory Clinical Study of a Laser-OCT Integrated System With Eye Tracking to Treat Glaucoma and OHT With Transscleral Selective Laser Trabeculoplasty Technology A Pilot Study
NCT06833060 is registered in ClinicalTrials.gov with Lumibird Medical (Quantel Medical, Ellex Medical, Optotek) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Clinical Study of a Laser-OCT Integrated System With Eye Tracking to Treat Glaucoma and OHT With Transscleral Selective Laser Trabeculoplasty Technology A Pilot Study
- Lead sponsor
- Lumibird Medical (Quantel Medical, Ellex Medical, Optotek)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 19, 2025
- Completion date
- July 30, 2026
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glaucoma,open-angle, ocular hypertension (oh)